Q4 2025 Earnings Call March 24, 2026 4:30 PM EDTCompany ParticipantsMiranda Benvenuti - Investor Relations ExecutivePeter Altman ...
Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 - ...
A real-world analysis of patients receiving teclistamab prior to 2022 showed comparable outcomes to clinical trials and ...
BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced it will ...
Innovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock ...
Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 - - Company announced first wholly owned dual-pay ...
Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting ...
Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus ...
Jeffrey Epstein's longtime personal attorney testified to a House committee Thursday that he was unaware of the late financier's sexual abuse of underage girls at the time ...
Start your morning with The National News Desk as Jan Jeffcoat sits down with cybersecurity and privacy attorney Leeza Garber ...
The Madness continues! Day 4 of the NCAA Women's Basketball is underway. Here's a look at Monday's matchups. (3) Louisville ...
President Donald Trump didn't mince words when he found out former FBI Director Robert S. Mueller III died.